EP1631235 - COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 26.04.2013 Database last updated on 31.08.2024 | Most recent event Tooltip | 26.04.2013 | Application deemed to be withdrawn | published on 29.05.2013 [2013/22] | Applicant(s) | For all designated states Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 / US | [2011/39] |
Former [2006/10] | For all designated states ISIS PHARMACEUTICALS, INC. 1896 Rutherford Road Carlsbad, CA 92008 / US | Inventor(s) | 01 /
BENNETT, Frank, C. 1347 Cassins Street Carlsbad, CA 92009 / US | 02 /
VICKERS, Timothy, A. 253 Luiseno Avenue Oceanside, CA 92057 / US | 03 /
KARRAS, James, G. 1159 Montura Road San Marcos, CA 92068 / US | 04 /
FREIER, Susan, M. 2946 Renault Street San Diego, CA 92112 / US | 05 /
BAKER, Brenda F. 2927 Rancho Cortes Carlsbad CA 92009 / US | [2006/24] |
Former [2006/10] | 01 /
BENNETT, Frank, C. 1347 Cassins Street Carlsbad, CA 92009 / US | ||
02 /
VICKERS, Timothy, A. 253 Luiseno Avenue Oceanside, CA 92057 / US | |||
03 /
KARRAS, James, G. 1159 Montura Road San Marcos, CA 92068 / US | |||
04 /
FREIER, Susan, M. 2946 Renault Street San Diego, CA 92112 / US | Representative(s) | Hallybone, Huw George, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2008/31] | Hallybone, Huw George, et al Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
Former [2008/28] | Hallybone, Huw George Carpmaels & Ransford 43-45 Bloomsbury Square London WC1A 2RA / GB | ||
Former [2006/22] | Manaton, Ross Timothy, et al Bromhead Johnson, Kingsbourne House, 229-231 High Holborn London WC1V 7DP / GB | ||
Former [2006/10] | Hale, Stephen Geoffrey, et al Bromhead Johnson, Kingsbourne House, 229-231 High Holborn London WC1V 7DP / GB | Application number, filing date | 04752823.7 | 19.05.2004 | [2006/10] | WO2004US15880 | Priority number, date | US20030444206 | 23.05.2003 Original published format: US 444206 | US20030510614P | 10.10.2003 Original published format: US 510614 P | US20030520401P | 13.11.2003 Original published format: US 520401 P | US20040537291P | 16.01.2004 Original published format: US 537291 P | [2006/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2005000202 | Date: | 06.01.2005 | Language: | EN | [2005/01] | Type: | A2 Application without search report | No.: | EP1631235 | Date: | 08.03.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.01.2005 takes the place of the publication of the European patent application. | [2006/10] | Search report(s) | International search report - published on: | US | 19.01.2006 | (Supplementary) European search report - dispatched on: | EP | 17.04.2008 | Classification | IPC: | C12N15/11, A61K48/00, A61P11/06 | [2008/20] | CPC: |
C12N15/1138 (EP);
A61P11/06 (EP);
C12N2310/11 (EP);
C12N2310/315 (EP);
C12N2310/321 (EP);
C12N2310/322 (EP);
| C-Set: |
C12N2310/321, C12N2310/3525 (EP)
|
Former IPC [2006/19] | A61K31/70, C12N5/00, C07H21/00 | ||
Former IPC [2006/10] | A61K6/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/10] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR MODULATION DER EXPRESSION VON B7 PROTEIN | [2006/10] | English: | COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | [2006/10] | French: | COMPOSITIONS ET METHODES DE MODULATION DE L'EXPRESSION DE LA PROTEINE B7 | [2006/10] | Entry into regional phase | 19.12.2005 | National basic fee paid | 19.12.2005 | Search fee paid | 19.12.2005 | Designation fee(s) paid | 19.12.2005 | Examination fee paid | Examination procedure | 19.12.2005 | Examination requested [2006/10] | 16.07.2008 | Amendment by applicant (claims and/or description) | 24.03.2010 | Despatch of a communication from the examining division (Time limit: M06) | 23.12.2010 | Reply to a communication from the examining division | 01.12.2012 | Application deemed to be withdrawn, date of legal effect [2013/22] | 09.01.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2013/22] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.03.2010 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 23.12.2010 | Request for further processing filed | 23.12.2010 | Full payment received (date of receipt of payment) Request granted | 14.01.2011 | Decision despatched | Fees paid | Renewal fee | 27.03.2006 | Renewal fee patent year 03 | 07.05.2007 | Renewal fee patent year 04 | 18.03.2008 | Renewal fee patent year 05 | 07.05.2009 | Renewal fee patent year 06 | 31.03.2010 | Renewal fee patent year 07 | 10.05.2011 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 31.05.2012 | 09   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [PY]WO03083089 (PPL THERAPEUTICS SCOTLAND LTD [GB], et al) [PY] 1-13* figure 1; example 1; claim 1; table 1; compound 1; sequence 1 *; | [Y] - QIAN S ET AL, "Administration of antisense oligodeoxyribonucleotides against mRNA of CD80 or CD86 prolongs survival of cardiac allografts by inhibition of CTL activity.", TRANSPLANTATION PROCEEDINGS 2001 FEB-MAR, (200102), vol. 33, no. 1-2, ISSN 0041-1345, page 551, XP002474973 [Y] 1-13 * the whole document * DOI: http://dx.doi.org/10.1016/S0041-1345(00)02137-0 | [Y] - LIANG X ET AL, "Phenotype and allostimulatory function of dendritic cells treated with antisense oligodeoxyribonucleotides targeting CD80 or CD86 mRNA.", TRANSPLANTATION PROCEEDINGS 2001 FEB-MAR, (200102), vol. 33, no. 1-2, ISSN 0041-1345, page 235, XP001036750 [Y] 1-13 * the whole document * DOI: http://dx.doi.org/10.1016/S0041-1345(00)01991-6 | [PY] - LIANG XIAOYAN ET AL, "Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.", TRANSPLANTATION 27 AUG 2003, (20030827), vol. 76, no. 4, ISSN 0041-1337, pages 721 - 729, XP002474974 [PY] 1-13 * the whole document * DOI: http://dx.doi.org/10.1097/01.TP.0000076470.35404.49 | International search | [X]US6319906 (BENNETT C FRANK [US], et al); | [X]WO0074687 (ISIS PHARMACEUTICALS INC [US], et al); | [Y]WO9901579 (ISIS PHARMACEUTICALS INC [US], et al) | Examination | WO0074687 | US6319906 | WO03083089 | - QIAN S ET AL, "Administration of antisense oligodeoxyribonucleotides against mRNA of CD80 or CD86 prolongs survival of cardiac allografts by inhibition of CTL activity", BIOSIS, BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, (200102), Database accession no. PREV200100372589 | - LIANG XIAOYAN ET AL, "Administration of dendritic cells transduced with antisense oligodeoxyribonucleotides targeting CD80 or CD86 prolongs allograft survival.", MEDLINE, US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US, (20030827), Database accession no. NLM12973117 | - LIANG X ET AL, "PHENOTYPE AND ALLOSTIMULATORY FUNCTION OF DENDRITIC CELLS TREATED WITH ANTISENSE OLIGODEOXYRIBONUCLEOTIDES TARGETING CD80 OR CD86 MRNA", TRANSPLANTATION PROCEEDINGS, ORLANDO, FL, US, (20010201), vol. 33, no. 1/02, ISSN 0041-1345, page 235, XP001036750 DOI: http://dx.doi.org/10.1016/S0041-1345(00)01991-6 |